Related Tags >> renal cell carcinoma Nexavar biopharmaceutical company Cancer Drugs

kidney cancer News

Most Popular kidney cancer Story

Antigenics gets world's first cancer vaccine approval

April 8, 2008 — 5:59am ET

Russia has improbably emerged as a world leader in new cancer vaccines. The country's regulatory body approved the use of Read more...

kidney cancer Press Releases

Van Andel Research Institute Findings Provide More Complete Picture of Kidney Cancer
BGI reports study results on frequent mutation of genes encoding UMPP components in kidney cancer
A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substant
Astellas Pharma Europe Ltd Wins Scrip Award for Licensing Deal of the Year
Two Metabolon Studies Provide Insight into Kidney Cancer for University of California Davis

Latest Headlines

UPDATED: Aveo shares sink on weak PhIII face-off with Nexavar
January 3, 2012
Novartis wins FDA approval for cancer blockbuster
March 31, 2009
Idera's cancer drug disappoints in Phase II
October 1, 2008
A deluge of pre-ASCO data hits the market
May 16, 2008
Report: Wilex, GPC nearing merger pact
May 7, 2008
Antigenics gets world's first cancer vaccine approval
April 8, 2008
Novartis ends cancer trial early after hitting endpoint
February 28, 2008
ALSO NOTED: Biogen snares first start-up for incubator; Alkermes gains from Reliance sale; Galapagos inks deal with Lilly; and
December 19, 2007
ALSO NOTED: Anadys names new CEO; Pfizer, Amgen gives to candidates; and much more...
August 27, 2007
Press Release: Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
June 27, 2007
Galil Medical gains $52M in VC
December 10, 2006
Bayer, Onyx announce disappointing Nexavar results
December 3, 2006
ALSO NOTED: Nektar closes UK site; Martines resigns from NSP; and much more...
July 26, 2006
Big pharmas reveal flood of cancer drugs at ASCO
June 4, 2006
Antigenics shares punished on Oncophage failure
March 23, 2006
FDA approves Pfizer's Sutent for cancer
January 26, 2006
FDA approves Nexavar for kidney cancer
December 20, 2005
Antigenics slashes staff in bid to conserve cash
December 6, 2005
ALSO NOTED: FDA wants more safety data on Pargluva; Genentech disappointed by Tarceva, Avastin combo; Schering takes stake in S
October 17, 2005
ALSO NOTED: Sorafenib NDA to get priority review; BioSante inks licensing deal; GTx to use FDA recommendations in trial; and mu
September 13, 2005

Paid Research Reports

More Research Reports >>